Under the agreement, twoXAR will use its proprietary artificial intelligence (AI ) technology to identify a set of lead compounds which demonstrate a novel mechanism of action and
The post Ono enters into research collaboration agreement with twoXAR appeared first on Pharmaceutical Business review.
Original Article: Ono enters into research collaboration agreement with twoXAR